Different points of action of retinoids and anti-estrogens in G1 phase identified in synchronized T-47D breast cancer cells

International Journal of Cancer

Volumn 70, Issue 3, 1997, Pages 291-296

  Wilcken, Nicholas R C ^a   Musgrove, Elizabeth A ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; MEVINOLIN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RETINOIC ACID;

ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; G1 PHASE; G2 PHASE; HUMANS; LOVASTATIN; POLYUNSATURATED ALKAMIDES; S PHASE; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031053209     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970127)70:3<291::AID-IJC8>3.0.CO;2-S     Document Type: Article

References (21)

1. ANZANO, M.A., BYERS, S.W., SMITH, J.M., PEER, C.W., MULLEN, L.T., BROWN, C.C., ROBERTS, A.B. and SPORN, M.B., Prevention of breast cancer in the rat with 9-m-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54, 4614-4617 (1994).
2. 1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases. Oncogene, 12, 753-763 (1996).
3. CLARKE, C.L., GRAHAM, J., ROMAN, S.D. and SUTHERLAND, R.L., Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the cancer cell Une T-47D. J. biol. Chem., 266, 18969-18975 (1991).
4. HALL, R.E., TILLEY, W.D., MCPHAUL, M.J. and SUTHERLAND, R.L., Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. Cancer, 52, 778-784 (1992).
5. JAKOBISIAK, M., BRUNO, S., SKIERSKI, J.S. and DARZYNKIEWICZ, Z., Cell cycle-specific effects of lovastatin. Proc. nat. Acad. Sci. (Wash.), 88, 3628-3632 (1991).
6. 1 to multiple cell cycles by lovastatin. Cancer Res., 51, 3602-3609 (1991).
7. LOTAN, R., Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res., 39, 1014-1019 (1979).
8. MARTH, C., BOCK, G. and DAXENBICHLER, G., Effect of 4-hydroxyphenylretinamide and retinoic acid on the proliferation and cell cycle of cultured human breast cancer cells. J. nat. Cancer Inst., 75, 871-875 (1985).
9. MCCORMICK, D.L. and MOON, R.C., Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis, 7, 193-196 (1986).
10. MOON, R.C., MEHTA, R.G. and DETRISAC, C.J., Retinoids as chemopreventive agents for breast cancer. Cancer Detection Prevention, 16, 73-79 (1992).
11. MUSGROVE, E.A., Hormonal control of breast cancer cell cycle progression. PhD thesis. University of NSW, Sydney (1992).
12. MUSGROVE, E.A., WAKELING, A.E. and SUTHERLAND, R.L., Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res., 49, 2398-2404 (1989).
13. RATKO, T.A., DETRISAC, C.J., DINGER, N.M., THOMAS, C.F., KELLOFF, G.J. and MOON, R.C., Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res., 49, 4472-4476 (1989).
14. RUBIN, M., FENIG, E., ROSENAUER, A., MENENDEZ-BOTET, C., ACHKAR, C., BENTEL, J.M., YAHALOM, J., MENDELSOHN, J. and MILLER, W.H.J., 9-cisretinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res., 54, 6549-6556 (1994).
15. 1 phase progression: cycling on cue. Cell, 79, 551-555 (1994).
16. 1 phase of the cell cycle. Europ. J. Cancer Clin. Oncol., 19, 615-621 (1983).
17. TAYLOR, I.W., HODSON, P.J., GREEN, M.D. and SUTHERLAND, R.L., Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res., 43, 4007-4010 (1983).
18. UEDA, H., TAKENAWA, T., MILLAN, J.C., GESELL, M.S. and BRANDES, D., The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer, 46, 2203-2209 (1980).
19. WATTS, C.K.W., BRADY, A., SARCEVIC, B., DEFAZIO, A., MUSGROVE, E.A. and SUTHERLAND, R.L., Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol., 9, 1804-1813 (1995).
20. WILCKEN, N.R.C., SARCEVIC, B., MUSGROVE, E.A. and SUTHERLAND, R.L., Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Differentiation, 7, 65-74 (1996).
21. ZHAO, Z., ZHANG, Z.-R, SOPRANO, D.R. and SOPRANO, K.J., Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Exp. Cell Res., 219, 555-561 (1995).